Name: 글로벌 시장 동향
SKU: MD1856
Availability: InStock

보고서 요약(국문)

개요
전 세계 심장 보조 장치 시장은 2022년 YY백만 달러에 도달했으며, 2023년부터 2030년까지 연평균 성장률(CAGR) YY%로 성장하여 2030년에는 YY백만 달러에 이를 것으로 예상됩니다.
심장 보조 장치(CAD)는 중증 심장 질환 환자의 순환 기능을 보조하는 혈액 펌프입니다. 이는 심장이 더 많은 혈액을 펌프질하도록 돕는 기계식 펌프 장치입니다. 심장에서 혈액을 가져와 신체의 다른 부위로 보내 심장의 부담을 덜어주는 방식으로 작동합니다.
또한, 심박 조율기는 가슴에 삽입하는 소형 의료 기기로, 전기 자극을 이용하여 심장이 정상 범위로 박동하도록 유도함으로써 비정상적인 심장 박동을 조절합니다. 심장 보조 장치는 현재 심장 이식 대기 기간 동안 중증 심부전 치료에 널리 사용되고 있습니다.
시장 동향: 동인 및 제약 요인
심부전 환자 수 증가
심부전 환자 수의 증가는 심장 보조 장치의 사용 및 적용 범위를 확대할 것입니다. 심장은 신체의 다른 부위에서 혈액을 심장으로 펌핑하는 역할을 합니다.
예를 들어, 2022년에 발표된 보고서에 따르면 전 세계적으로 심부전 유병률이 약 2,600만 명에 달하며, 이는 전 세계 의료비 증가의 원인이 되고 있습니다. 심부전은 높은 이환율과 사망률을 보이는 세계적인 질환입니다.
또한, 미국심장협회(AHA) 저널에 발표된 보고서에 따르면 심부전 유병률은 약 600만 명으로, 미국 전체 인구의 약 1.8%에 해당합니다. 연구진은 2030년까지 심부전 유병률이 46% 증가하여 미국에서 800만 명 이상에 이를 것으로 예측했습니다. 따라서 심부전 환자 수의 증가는 시장 성장을 촉진할 것으로 예상됩니다.
제한 요인
기기 및 시술 비용의 상승
기기 및 시술 비용의 상승은 시장 성장을 저해할 수 있습니다. 치료 비용을 감당할 수 있는 사람이 소수에 불과하기 때문입니다. 초기 입원을 포함한 123일간의 치료에 대한 총 비용은 LVAD의 경우 197,957달러, 심장 이식의 경우 151,646달러였습니다.
세그먼트 분석
전 세계 심장 보조 장치 시장은 제품, 적용 분야, 최종 사용자 및 지역별로 세분화됩니다.
심실 보조 장치(VAD) 부문은 시장 점유율의 48.3%를 차지했습니다.
심실 보조 장치(VAD) 부문은 전 세계 심장 보조 장치 시장에서 지배적인 점유율을 차지할 것으로 예상됩니다. 심실 보조 장치(VAD)는 심장의 하부 심실에서 신체의 나머지 부분으로 혈액을 펌핑하는 것을 돕는 장치입니다. 다른 유형의 장치에 비해 VAD의 장점이 이 부문을 지배적인 위치로 유지하는 요인입니다.
좌심실 보조 장치(LVAD)는 진행성 심부전 환자에게 이식되는 기계 장치로, 심장이 혈액을 더 효율적으로 펌핑하도록 돕고, 기증자를 기다리는 진행성 심부전 환자에게 도움이 될 수 있습니다. LVAD는 신체로의 혈류를 증가시켜 신장, 간, 뇌 및 기타 장기의 기능을 개선합니다. 또한, 심장 질환 환자 수 증가, 고령 인구 증가, 그리고 관련 기기 출시 증가 등이 해당 부문의 성장을 견인할 것으로 예상됩니다. 따라서 위의 요인들은 시장 점유율에 상당한 영향을 미칠 것으로 보입니다.
지역 분석
북미는 전 세계 심장 보조 장치 시장에서 상당한 점유율을 차지할 것으로 예상됩니다.
북미는 심장 보조 장치 분야의 기술 발전과 심장 질환 유병률 증가로 인해 심장 보조 장치 시장에서 지배적인 위치를 차지하고 있으며, 이러한 추세는 예측 기간 동안 지속될 것으로 예상됩니다.
예를 들어, 2023년 7월 11일 SynCardia Systems, LLC.는 실제 데이터를 기반으로 SynCardia TAH-t 라벨 업데이트에 대해 미국 식품의약국(FDA)의 승인을 받았으며, 이는 Companion 2 Driver의 안전성과 성능을 더욱 확증하는 것입니다.

또한, 2022년 8월 29일, 자사의 HeartMate 3 심장 펌프가 진행성 심부전 환자의 생존 기간을 최소 5년 이상 연장한다는 새로운 최신 데이터가 발표되었습니다. 이는 말기 심부전 환자들에게 생명을 구할 수 있는 확실한 선택지를 제공하며, HeartMate 3는 2020년 미국에서 승인을 받았습니다. 따라서 위의 요인들이 이 지역 시장 성장을 견인할 것으로 예상됩니다.

COVID-19 영향 분석
COVID-19는 심장 보조 장치 시장에 부정적인 영향을 미쳤습니다. 심혈관 수술 건수 감소와 봉쇄 기간 동안 병원 폐쇄는 시장 성장에 악영향을 미쳤습니다. 사람들은 바이러스 확산으로 인해 치료를 위해 병원을 방문하는 것을 꺼렸습니다.

경쟁 환경
상당한 시장 점유율을 차지하는 주요 기업으로는 Medtronic Plc, Abiomed Inc., SynCardia Systems, Calon Cardio-Technology Ltd., Teleflex Incorporated, Abbott Laboratories, BiVACOR Inc., Berlin Heart GmbH, EVAHEART, INC., 및 Jarvik Heart, Inc. 등이 있습니다.
주요 동향
• 2023년 1월 24일, 일본 최대 의료기기 제조업체인 테루모(Terumo)는 미국에 완전 자회사를 설립하고 좌심실 보조 장치(LVAD) 사업을 미국에서 시작했습니다.
• 2021년 6월 26일, CARMAT는 독일에서 자사의 Aeson 생체 인공 심장을 최초로 이식했습니다.
보고서 구매 이유

• 제품, 적용 분야, 최종 사용자 및 지역별 글로벌 심장 보조 장치 시장 세분화를 시각화하고 주요 상업 자산 및 기업을 파악하기 위해

• 트렌드 및 공동 개발 분석을 통해 사업 기회를 식별하기 위해

• 모든 세그먼트를 포함한 심장 보조 장치 시장 수준의 다양한 데이터가 담긴 엑셀 데이터 시트.

• 심층적인 질적 인터뷰와 연구를 바탕으로 한 종합적인 분석이 담긴 PDF 보고서.

• 주요 업체들의 핵심 제품을 모두 포함하는 제품 맵핑 엑셀 파일 제공.
글로벌 심장 보조 장치 시장 보고서는 약 59개의 표, 61개의 그림, 187페이지 분량입니다.
주요 독자층 (2023년 기준)
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
Global Cardiac Assist Devices Market reached US$ YY million in 2022 and is expected to reach US$ YY million by 2030, growing at a CAGR of YY% during the forecast period 2023-2030.
Cardiac assist devices (CAD) are blood pumps that support the circulatory functions of severely ill cardiac patients. These are mechanical pumping devices designed to help the heart pump more blood. They work by taking blood from the heart and pumping it to the rest of the body, thus taking the burden off the heart.
These are small medical devices placed in the chest, a pacemaker helps control abnormal heart rhythms by using electrical pulses to prompt the heart to beat at a normal range. Cardiac assist devices are now commonly used in the treatment of severe heart failure as bridges to cardiac transplants.
Market Dynamics: Drivers & Restraints
Increase in the number of heart failure cases
An increase in the number of heart failure cases will increase the usage and application of cardiac assist devices. They help in pumping blood to the heart from other parts of the body.
For instance, according to the report published in 2022, it is estimated that heart failure has an estimated prevalence of 26 million people worldwide and contributes to increased healthcare costs worldwide. Heart failure remains a highly prevalent disorder worldwide with a high morbidity and mortality rate.
Additionally, according to the report published by AHA Journal, it is estimated that the prevalence of heart failure is 6 million, approximately 1.8% of the total US population. It also said that researchers have predicted a 46% increase in heart failure prevalence by 2030, reaching more than 8 million people in the US. Thus, the increase in the number of heart failures is expected to raise the market growth.
Restraint
High costs of devices and the procedures
Increasing costs for the devices and procedures can hamper the market growth, as only few individuals can afford the treatment procedure cost. The overall cost for the 123 days of care including initial hospitalization was $197 957 for LVADs and $151 646 for heart transplants.
Segment Analysis
The global cardiac assist devices market is segmented based on product, application, end-user, and region.
Ventricular assist device segment accounted for 48.3% of the market share
Ventricular assist devices segment is expected to hold a dominant share in the global cardiac assist devices market. A ventricular assist device (VAD) is a device that helps pump blood from the lower chambers of the heart to the rest of the body. The advantages of the devices over other types are holding the segment in the dominant position.
Left Ventricular Assist Devices (LVADs) are mechanical devices that are implanted in patients with advanced heart failure, help the heart pump blood more effectively, and could benefit patients with advanced heart failure as they await donors. They improve the function of the kidneys, liver, brain, and other organs by increasing blood flow to the body.
Additionally, the increase in the number of heart diseases, and increase in the geriatric population, and the increase in the number of launches of the devices are expected to drive the segment’s growth. Thus, the above factors are expected to hold a significant position in the market share.
Geographical Analysis
North America is expected to hold a significant position in the global cardiac assist devices market share
North America holds a dominant share in the cardiac assist devices market share owing to the technological advancements in the field of cardiac assist devices and the rise in the prevalence of heart diseases which is expected to continue throughout the forecast period.
For instance, on July 11, 2023, SynCardia Systems, LLC., received the U.S. Food and Drug Administration (FDA) approval for the update of the SynCardia TAH-t label with real-world data further confirming the safety and performance of the Companion 2 Driver.
Additionally, on August 29, 2022, has released new late-breaking data that show its HeartMate 3 heart pump extends the survival of advanced heart failure patients by at least five years, providing a clear life-saving option for people battling later-stage disease for which it has received the US approval in 2020. Thus, the above factors are expected to drive the market growth in this region.
COVID-19 Impact Analysis
The COVID-19 has impacted the cardiac assist devices market negatively. The reduction in the number of cardiovascular surgeries and the closure of hospitals during the period of lockdown has impacted the market growth. People refused to visit hospitals for treatment procedures because of the spread of the virus.
Competitive Landscape
The leading companies with a significant market share include Medtronic Plc, Abiomed Inc., SynCardia Systems, Calon Cardio-Technology Ltd., Teleflex Incorporated, Abbott Laboratories, BiVACOR Inc., Berlin Heart GmbH, EVAHEART, INC., and Jarvik Heart, Inc.
Key Developments
• On January 24, 2023, Terumo, Japan's largest maker of medical supplies, established a wholly-owned subsidiary in the US. It has launched the US LVAD (left ventricular heart assist device) business.
• On June 26, 2021, CARMAT introduced the first implant of its Aeson bioprosthetic artificial heart in Germany.
Why Purchase the Report?
• To visualize the global cardiac assist devices market segmentation based on product, application, end-user, and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of cardiac assist devices market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global cardiac assist devices market report would provide approximately 59 tables, 61 figures, and 187 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

Table of Contents
1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product
3.2. Snippet by Application
3.3. Snippet by End-User
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increase in the number of heart failure cases
4.1.1.2. YY
4.1.2. Restraints
4.1.2.1. High costs associated with the devices and procedures
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
7.1.2. Market Attractiveness Index, By Product
7.2. Ventricular Assist Device *
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Total Artificial Heart
7.4. Intra-Aortic Balloon Pump
7.5. Others
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Bridge-to-transplant (BTT) Therapy *
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Destination Therapy
8.4. Others
9. By End-User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals *
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Clinics
9.4. Ambulatory Surgical Centers
9.5. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. UK
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Medtronic Plc *
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Abiomed Inc.
12.3. SynCardia Systems
12.4. Calon Cardio-Technology Ltd.
12.5. Teleflex Incorporated
12.6. Abbott Laboratories
12.7. BiVACOR Inc.
12.8. Berlin Heart GmbH
12.9. EVAHEART, INC.
12.10. Jarvik Heart, Inc.
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us

언급된 주요 기업들

Medtronic Plc, 4. Key Developments, Abiomed Inc., SynCardia Systems, Calon Cardio-Technology Ltd., Teleflex Incorporated, Abbott Laboratories, BiVACOR Inc., Berlin Heart GmbH, EVAHEART, INC., Jarvik Heart, Inc.

표 목록 (Tables)

List of Tables

Table 1 Global Cardiac Assist Devices Market Value, By Product, 2022, 2026 & 2030 (US$ Million)

Table 2 Global Cardiac Assist Devices Market Value, By Application, 2022, 2026 & 2030 (US$ Million)

Table 3 Global Cardiac Assist Devices Market Value, By End-User, 2022, 2026 & 2030 (US$ Million)

Table 4 Global Cardiac Assist Devices Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 5 Global Cardiac Assist Devices Market Value, By Product, 2022, 2026 & 2030 (US$ Million)

Table 6 Global Cardiac Assist Devices Market Value, By Product, 2021-2030 (US$ Million)

Table 7 Global Cardiac Assist Devices Market Value, By Application, 2022, 2026 & 2030 (US$ Million)

Table 8 Global Cardiac Assist Devices Market Value, By Application, 2021-2030 (US$ Million)

Table 9 Global Cardiac Assist Devices Market Value, By End-User, 2022, 2026 & 2030 (US$ Million)

Table 10 Global Cardiac Assist Devices Market Value, By End-User, 2021-2030 (US$ Million)

Table 11 Global Cardiac Assist Devices Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 12 Global Cardiac Assist Devices Market Value, By Region, 2021-2030 (US$ Million)

Table 13 North America Cardiac Assist Devices Market Value, By Product, 2021-2030 (US$ Million)

Table 14 North America Cardiac Assist Devices Market Value, By Application, 2021-2030 (US$ Million)

Table 15 North America Cardiac Assist Devices Market Value, By End-User, 2021-2030 (US$ Million)

Table 16 North America Cardiac Assist Devices Market Value, By Country, 2021-2030 (US$ Million)

Table 17 South America Cardiac Assist Devices Market Value, By Product, 2021-2030 (US$ Million)

Table 18 South America Cardiac Assist Devices Market Value, By Application, 2021-2030 (US$ Million)

Table 19 South America Cardiac Assist Devices Market Value, By End-User, 2021-2030 (US$ Million)

Table 20 South America Cardiac Assist Devices Market Value, By Country, 2021-2030 (US$ Million)

Table 21 Europe Cardiac Assist Devices Market Value, By Product, 2021-2030 (US$ Million)

Table 22 Europe Cardiac Assist Devices Market Value, By Application, 2021-2030 (US$ Million)

Table 23 Europe Cardiac Assist Devices Market Value, By End-User, 2021-2030 (US$ Million)

Table 24 Europe Cardiac Assist Devices Market Value, By Country, 2021-2030 (US$ Million)

Table 25 Asia-Pacific Cardiac Assist Devices Market Value, By Product, 2021-2030 (US$ Million)

Table 26 Asia-Pacific Cardiac Assist Devices Market Value, By Application, 2021-2030 (US$ Million)

Table 27 Asia-Pacific Cardiac Assist Devices Market Value, By End-User, 2021-2030 (US$ Million)

Table 28 Asia-Pacific Cardiac Assist Devices Market Value, By Country, 2021-2030 (US$ Million)

Table 29 Middle East & Africa Cardiac Assist Devices Market Value, By Product, 2021-2030 (US$ Million)

Table 30 Middle East & Africa Cardiac Assist Devices Market Value, By Application, 2021-2030 (US$ Million)

Table 31 Middle East & Africa Cardiac Assist Devices Market Value, By End-User, 2021-2030 (US$ Million)

Table 32 Medtronic Plc: Overview

Table 33 Medtronic Plc: Product Portfolio

Table 34 Medtronic Plc: Key Developments

Table 35 Abiomed Inc.: Overview

Table 36 Abiomed Inc.: Product Portfolio

Table 37 Abiomed Inc.: Key Developments

Table 38 SynCardia Systems: Overview

Table 39 SynCardia Systems: Product Portfolio

Table 40 SynCardia Systems: Key Developments

Table 41 Calon Cardio-Technology Ltd.: Overview

Table 42 Calon Cardio-Technology Ltd.: Product Portfolio

Table 43 Calon Cardio-Technology Ltd.: Key Developments

Table 44 Teleflex Incorporated: Overview

Table 45 Teleflex Incorporated: Product Portfolio

Table 46 Teleflex Incorporated: Key Developments

Table 47 Abbott Laboratories: Overview

Table 48 Abbott Laboratories: Product Portfolio

Table 49 Abbott Laboratories: Key Developments

Table 50 BiVACOR Inc.: Overview

Table 51 BiVACOR Inc.: Product Portfolio

Table 52 BiVACOR Inc.: Key Developments

Table 53 Berlin Heart GmbH: Overview

Table 54 Berlin Heart GmbH: Product Portfolio

Table 55 Berlin Heart GmbH: Key Developments

Table 56 EVAHEART, INC.: Overview

Table 57 EVAHEART, INC.: Product Portfolio

Table 58 EVAHEART, INC.: Key Developments

Table 59 Jarvik Heart, Inc.: Overview

Table 60 Jarvik Heart, Inc.: Product Portfolio

Table 61 Jarvik Heart, Inc.: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Cardiac Assist Devices Market Value, 2021-2030 (US$ Million)

Figure 2 Global Cardiac Assist Devices Market Share, By Product, 2022 & 2030 (%)

Figure 3 Global Cardiac Assist Devices Market Share, By Application, 2022 & 2030 (%)

Figure 4 Global Cardiac Assist Devices Market Share, By End-User, 2022 & 2030 (%)

Figure 5 Global Cardiac Assist Devices Market Share, By Region, 2022 & 2030 (%)

Figure 6 Global Cardiac Assist Devices Market Y-o-Y Growth, By Product, 2022-2030 (%)

Figure 7 Ventricular Assist Device Cardiac Assist Devices Market Value, 2021-2030 (US$ Million)

Figure 8 Total Artificial Heart Cardiac Assist Devices Market Value, 2021-2030 (US$ Million)

Figure 9 Intra-Aortic Balloon Pump Cardiac Assist Devices Market Value, 2021-2030 (US$ Million)

Figure 10 Others Cardiac Assist Devices Market Value, 2021-2030 (US$ Million)

Figure 11 Global Cardiac Assist Devices Market Y-o-Y Growth, By Application, 2022-2030 (%)

Figure 12 Bridge-to-transplant (BTT) Therapy Application in Global Cardiac Assist Devices Market Value, 2021-2030 (US$ Million)

Figure 13 Destination Therapy Application in Global Cardiac Assist Devices Market Value, 2021-2030 (US$ Million)

Figure 14 Others Application in Global Cardiac Assist Devices Market Value, 2021-2030 (US$ Million)

Figure 15 Global Cardiac Assist Devices Market Y-o-Y Growth, By End-User, 2022-2030 (%)

Figure 16 Hospitals End-User in Global Cardiac Assist Devices Market Value, 2021-2030 (US$ Million)

Figure 17 Specialty Clinics End-User in Global Cardiac Assist Devices Market Value, 2021-2030 (US$ Million)

Figure 18 Ambulatory Surgical Centers End-User in Global Cardiac Assist Devices Market Value, 2021-2030 (US$ Million)

Figure 19 Others End-User in Global Cardiac Assist Devices Market Value, 2021-2030 (US$ Million)

Figure 20 Global Cardiac Assist Devices Market Y-o-Y Growth, By Region, 2022-2030 (%)

Figure 21 North America Cardiac Assist Devices Market Value, 2021-2030 (US$ Million)

Figure 22 Asia-Pacific Cardiac Assist Devices Market Value, 2021-2030 (US$ Million)

Figure 23 Europe Cardiac Assist Devices Market Value, 2021-2030 (US$ Million)

Figure 24 South America Cardiac Assist Devices Market Value, 2021-2030 (US$ Million)

Figure 25 Middle East and Africa Cardiac Assist Devices Market Value, 2021-2030 (US$ Million)

Figure 26 North America Cardiac Assist Devices Market Value, 2021-2030 (US$ Million)

Figure 27 North America Cardiac Assist Devices Market Share, By Product, 2022 & 2030 (%)

Figure 28 North America Cardiac Assist Devices Market Share, By Application, 2022 & 2030 (%)

Figure 29 North America Cardiac Assist Devices Market Share, By End-User, 2022 & 2030 (%)

Figure 30 North America Cardiac Assist Devices Market Share, By Country, 2022 & 2030 (%)

Figure 31 South America Cardiac Assist Devices Market Value, 2021-2030 (US$ Million)

Figure 32 South America Cardiac Assist Devices Market Share, By Product, 2022 & 2030 (%)

Figure 33 South America Cardiac Assist Devices Market Share, By Application, 2022 & 2030 (%)

Figure 34 South America Cardiac Assist Devices Market Share, By End-User, 2022 & 2030 (%)

Figure 35 South America Cardiac Assist Devices Market Share, By Country, 2022 & 2030 (%)

Figure 36 Europe Cardiac Assist Devices Market Value, 2021-2030 (US$ Million)

Figure 37 Europe Cardiac Assist Devices Market Share, By Product, 2022 & 2030 (%)

Figure 38 Europe Cardiac Assist Devices Market Share, By Application, 2022 & 2030 (%)

Figure 39 Europe Cardiac Assist Devices Market Share, By End-User, 2022 & 2030 (%)

Figure 40 Europe Cardiac Assist Devices Market Share, By Country, 2022 & 2030 (%)

Figure 41 Asia-Pacific Cardiac Assist Devices Market Value, 2021-2030 (US$ Million)

Figure 42 Asia-Pacific Cardiac Assist Devices Market Share, By Product, 2022 & 2030 (%)

Figure 43 Asia-Pacific Cardiac Assist Devices Market Share, By Application, 2022 & 2030 (%)

Figure 44 Asia-Pacific Cardiac Assist Devices Market Share, By End-User, 2022 & 2030 (%)

Figure 45 Asia-Pacific Cardiac Assist Devices Market Share, By Country, 2022 & 2030 (%)

Figure 46 Middle East & Africa Cardiac Assist Devices Market Value, 2021-2030 (US$ Million)

Figure 47 Middle East & Africa Cardiac Assist Devices Market Share, By Product, 2022 & 2030 (%)

Figure 48 Middle East & Africa Cardiac Assist Devices Market Share, By Application, 2022 & 2030 (%)

Figure 49 Middle East & Africa Cardiac Assist Devices Market Share, By End-User, 2022 & 2030 (%)

Figure 50 Medtronic Plc: Financials

Figure 51 Abiomed Inc.: Financials

Figure 52 SynCardia Systems: Financials

Figure 53 Calon Cardio-Technology Ltd.: Financials

Figure 54 Teleflex Incorporated: Financials

Figure 55 Abbott Laboratories: Financials

Figure 56 BiVACOR Inc.: Financials

Figure 57 Berlin Heart GmbH: Financials

Figure 58 EVAHEART, INC.: Financials

Figure 59 Jarvik Heart, Inc.: Financials

글로벌 심장 보조 장치 시장 – 2023-2030

Global Cardiac Assist Devices Market - 2023-2030